4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS 220000-87-3
Commercial Supple Sorafenib Tosylate et intermedia:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4-(4-Aminophenoxy)-N-Methylpicolamide CAS:
4-Chloro-3-(Trifluoromethyl) phenyl Isocyanate CAS: 327-78-6
| Nomen chemicum | 4-Chloro-N-Methyl-2-Pyridinecarboxamide |
| Synonyma | 4-Chloro-N-Methylpicolamide;N-Methyl-4-Chloropyridine-2-Carboxamide;4-Chloro-N-Methylpyridine-2-Carboxamide |
| CAS Number | 220000-87-3 |
| CATTUS Number | RF-PI165 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C7H7ClN2O |
| M. Pondus | 170.60 |
| Liquescens punctum | 41.0~ 438.0℃ |
| Ferveret | 317.8℃ ad 760 mmHg |
| Density | 1.264 g/cm3 |
| Solubilitas (Solubile in) | Methanol, Ethylacetate |
| Shipping Conditions | Ambiens |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Off-White ad lux Yellow pulveris |
| Lepidium sativum | (1) MS (2) 1H-NMR |
| Puritas / Analysis Methodus | 98.0%~ 101.0% (ex sicca basis) (HPLC) |
| Humor (KF) | ≤1.0% |
| Damnum in Siccatio | ≤1.0% |
| Metalla gravis | ≤20ppm |
| una immunditia | ≤1.0% |
| Totalis immunditias | ≤2.0% |
| Test Standard | Enterprise Standard |
| Consuetudinem | Intermedia Sorafenib Tosylate (CAS: 475207-59-1) |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum 4-Chloro-N-Methyl-2-pyridinecarboxamidei (CAS: 220000-87-3) cum magna qualitate, medium est typice in synthesi Tosylate Sorafenib. CAS: 475207-59-1).Sorafenib Tosylate novum genus pharmaci antitumoris multi-scopi est, a Germanico Bayer Pharmaceuticis enucleatum est, et actionem expansivam in preclinicis probat animali ostendit.Sorafenib praesto est in tabulis CC-mg pro administratione oralis adhibenda in curatione RCC et HCC.Sorafenib Tosylate (CAS: 475207-59-1) potest simul afficere cellas tumorem et vasa sanguinis tumorem.
